Provided by Tiger Fintech (Singapore) Pte. Ltd.

PTC Therapeutics

51.34
-0.5300-1.02%
Volume:309.24K
Turnover:15.97M
Market Cap:4.07B
PE:6.83
High:52.45
Open:51.74
Low:51.10
Close:51.87
Loading ...

Countdown to PTC Therapeutics (PTCT) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS

Zacks
·
24 Feb

Hold Rating on PTC Therapeutics Amidst Mixed Outcomes for Vatiquinone in Friedreich’s Ataxia Treatment

TIPRANKS
·
19 Feb

PTC Therapeutics Says FDA Grants Priority Review to Vatiquinone NDA for Treating Friedreich's Ataxia; Shares Up Pre-Bell

MT Newswires Live
·
19 Feb

BRIEF-Ptc Therapeutics Announces FDA Acceptance And Priority Review For Vatiquinone NDA

Reuters
·
19 Feb

PTC Therapeutics Inc - Pdufa Target Action Date of Aug. 19, 2025

THOMSON REUTERS
·
19 Feb

PTC Therapeutics Announces FDA Acceptance and Priority Review for Vatiquinone Nda for the Treatment of Children and Adults With Friedreich's Ataxia

THOMSON REUTERS
·
19 Feb

PTC Therapeutics Is Maintained at Outperform by RBC Capital

Dow Jones
·
19 Feb

RBC Capital Adjusts PTC Therapeutics Price Target to $63 From $60, Maintains Outperform Rating

MT Newswires Live
·
18 Feb

PTC Therapeutics Inc : RBC Raises Target Price to $63 From $60

THOMSON REUTERS
·
18 Feb

PTC Therapeutics price target raised to $45 from $32 at Citi

TIPRANKS
·
12 Feb

PTC Therapeutics (PTCT) Moves 9.0% Higher: Will This Strength Last?

Zacks
·
04 Feb

Why PTC Therapeutics (PTCT) Stock Is Rallying Today

Insider Monkey
·
04 Feb

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
03 Feb

PTC Therapeutics price target raised to $113 from $76 at Cantor Fitzgerald

TIPRANKS
·
03 Feb

PTC Therapeutics (PTCT) Receives a Hold from Leerink Partners

TIPRANKS
·
22 Jan

U.S. RESEARCH ROUNDUP- Apple, Murphy USA, UnitedHealth

Reuters
·
21 Jan

Cantor Fitzgerald Sticks to Its Buy Rating for PTC Therapeutics (PTCT)

TIPRANKS
·
15 Jan

PTC Therapeutics Is Maintained at Overweight by Cantor Fitzgerald

Dow Jones
·
15 Jan

Cautious Outlook on PTC Therapeutics Amid Regulatory and Financial Challenges

TIPRANKS
·
15 Jan

BRIEF-Orsini Chosen By PTC Therapeutics As Exclusive Specialty Pharmacy Provider For Adeno-Associated Virus Vector-Based Gene Therapy KEBILIDI™

Reuters
·
14 Jan